Not independent
Tenure on this board
2.1 yrs
Meeting calendar
CON · Annual meeting · Thursday, April 30, 2026
Concentra Group Holdings Parent Inc
3 nominees · 3 ballot items.
Elect three Class II directors; advisory vote to approve named executive officer compensation (say-on-pay); ratify PricewaterhouseCoopers LLP as independent auditors for fiscal 2026; and transact any other business properly before the meeting.
Market cap
$4.0B
1Y TSR
+52.5%
Board grade
B
Record date
Mar 5, 2026
Filing
DEF 14A
Meeting concluded · Apr 30, 2026
Follow how the vote landed and what changed on Concentra Group Holdings Parent Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElect Vipin Gopal, William K. Newton, and Marc R. Watkins, MD as Class II directors, each for a term of three years and until their respective successors are elected and qualified.
- 2
Non-binding advisory vote on the compensation of our Named Executive Officers (Say-on-Pay
ManagementBoard: FORAdvisory (non-binding) approval of the compensation of the company's named executive officers as disclosed in the proxy statement.
More detail
This non-binding advisory proposal asks shareholders to approve the overall compensation of the company’s named executive officers as disclosed in the proxy statement. Management and the Human Capital and Compensation Committee seek this advisory approval to gauge investor support for the executive compensation program and to demonstrate responsiveness to stockholder views; the committee has historically considered prior say-on-pay results (78.4% support in 2025) when evaluating compensation. The proposal is advisory only and does not bind the company, but the Human Capital and Compensation Committee will take the outcome into account in future compensation design. Key context includes the company’s emphasis on performance-based pay (EBITDA and EPS metrics, equity awards), stock ownership guidelines, and compensation recovery policies aligned to NYSE and SEC rules. The board recommends a FOR vote citing alignment of pay with performance, safeguards against risky incentives (recovery policy), and past shareholder support as justification. A sophisticated evaluation should weigh the company's pay-for-performance linkages, the significant equity-heavy compensation for the CEO in 2025, potential dilution from equity plans, and governance features such as clawbacks and ownership guidelines when assessing whether the advisory vote outcome indicates sufficient shareholder alignment.
- 3
Ratification of appointment of independent registered public accounting firm
ManagementBoard: FORRatify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
Director elections
Nominees on the ballot3
Independent
Tenure on this board
2.1 yrs
Independent
Tenure on this board
1.1 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | PRICE T ROWE ASSOCIATES INC /MD/ | 13.2% | 16,859,023 | $362M |
| 2 | BlackRock, Inc. | 9.7% | 12,445,468 | $267M |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.3% | 6,738,925 | $145M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.0% | 5,095,516 | $109M |
| 5 | STATE STREET CORP | 3.6% | 4,602,825 | $99M |
| 6 | BlackRock, Inc. | 2.6% | 3,353,357 | $72M |
| 7 | DIMENSIONAL FUND ADVISORS LP | 2.3% | 2,913,173 | $62M |
| 8 | T. Rowe Price Investment Management, Inc. | 2.0% | 2,562,528 | $55M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.0% | 2,519,559 | $54M |
| 10 | JPMORGAN CHASE CO | 1.8% | 2,366,478 | $50M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Concentra Group Holdings Parent Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Doximity IncDOCS
Annual meeting·Aug 27, 2026·$3.9B
Organon & CoOGN
Special meeting·Jul 23, 2026·$3.6B
Haemonetics CorpHAE
Annual meeting·Jul 24, 2026·$3.5B
Amneal Pharmaceuticals IncAMRX
Special meeting·Jul 31, 2026·$5.7B
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.4B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.7B
Reference
Frequently asked questions
- When is the Concentra Group Holdings Parent Inc 2026 annual meeting?
- Concentra Group Holdings Parent Inc (CON) holds its 2026 annual shareholder meeting on Thursday, April 30, 2026.
- What is the record date for the Concentra Group Holdings Parent Inc 2026 meeting?
- The record date for the Concentra Group Holdings Parent Inc 2026 meeting is Thursday, March 5, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Concentra Group Holdings Parent Inc's 2026 meeting?
- The board is presenting 3 director nominees at the Concentra Group Holdings Parent Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Concentra Group Holdings Parent Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Concentra Group Holdings Parent Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.